PRAXPraxis Precision Medicines,...

Nasdaq praxismedicines.com


$ 41.20 $ -0.17 (-0.41 %)    

Monday, 01-Jul-2024 15:59:32 EDT
QQQ $ 481.74 $ 2.81 (0.59 %)
DIA $ 391.56 $ 0.33 (0.08 %)
SPY $ 545.33 $ 1.12 (0.21 %)
TLT $ 90.13 $ -1.58 (-1.73 %)
GLD $ 215.59 $ 0.56 (0.26 %)
$ 41.19
$ 40.86
$ 0.00 x 0
$ 0.00 x 0
$ 39.88 - $ 41.91
$ 12.75 - $ 67.21
426,798
na
572.72M
$ -0.05
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-13-2024 03-31-2024 10-Q
2 03-05-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-09-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 02-07-2023 12-31-2022 10-K
7 11-09-2022 09-30-2022 10-Q
8 08-08-2022 06-30-2022 10-Q
9 05-09-2022 03-31-2022 10-Q
10 02-28-2022 12-31-2021 10-K
11 11-03-2021 09-30-2021 10-Q
12 08-16-2021 06-30-2021 10-Q
13 05-11-2021 03-31-2021 10-Q
14 03-17-2021 12-31-2020 10-K
15 11-23-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 piper-sandler-maintains-overweight-on-praxis-precision-medicine-maintains-270-price-target

Piper Sandler analyst Yasmeen Rahimi maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Overweight and maintains $270 ...

 value-of-praxis-precision-medicines-lead-program-in-essential-tremor-alone-is-underappreciated-analyst

Needham rates Praxis Precision Medicines Buy with a $145 target. Key programs include ulixacaltamide for essential tremor (Phas...

 needham-initiates-coverage-on-praxis-precision-medicine-with-buy-rating-announces-price-target-of-145

Needham analyst Ami Fadia initiates coverage on Praxis Precision Medicine (NASDAQ:PRAX) with a Buy rating and announces Pric...

 guggenheim-initiates-coverage-on-praxis-precision-medicine-with-buy-rating-announces-price-target-of-155

Guggenheim analyst Yatin Suneja initiates coverage on Praxis Precision Medicine (NASDAQ:PRAX) with a Buy rating and announce...

 truist-securities-maintains-buy-on-praxis-precision-medicine-maintains-150-price-target

Truist Securities analyst Joon Lee maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and maintains $150 price tar...

 hc-wainwright--co-reiterates-buy-on-praxis-precision-medicine-maintains-105-price-target

HC Wainwright & Co. analyst Douglas Tsao reiterates Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and maintains $10...

 praxis-precision-medicines-advances-precision-therapies-for-cns-disorders-anticipates-key-milestones-in-seizure-and-pediatric-epilepsy-treatment

 Praxis Precision Medicines, Inc. (NASDAQ:PRAX), a clinical-stage biopharmaceutical company translating genetic insights into t...

 baird-initiates-coverage-on-praxis-precision-medicine-with-outperform-rating-announces-price-target-of-117

Baird analyst Joel Beatty initiates coverage on Praxis Precision Medicine (NASDAQ:PRAX) with a Outperform rating and announc...

 hc-wainwright--co-reiterates-buy-on-praxis-precision-medicine-maintains-105-price-target

HC Wainwright & Co. analyst Douglas Tsao reiterates Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and maintains $10...

 praxis-precision-medicines-priced-200m-offering-of-33m-shares-at-5650share

Praxis Precision Medicines, Inc. (NASDAQ:PRAX), a clinical-stage biopharmaceutical company translating genetic insights into th...

 why-westport-fuel-systems-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected ...

 jefferies-maintains-buy-on-praxis-precision-medicine-raises-price-target-to-128

Jefferies analyst Kambiz Yazdi maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and raises the price target from...